OvaScience Inc. (OVAS) to Release Earnings on Wednesday
OvaScience Inc. (NASDAQ:OVAS) is scheduled to be posting its quarterly earnings results after the market closes on Wednesday, November 1st. Analysts expect OvaScience to post earnings of ($0.39) per share for the quarter.
OvaScience (NASDAQ:OVAS) last released its quarterly earnings data on Thursday, August 3rd. The biotechnology company reported ($0.45) earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of ($0.47) by $0.02. The firm had revenue of $0.08 million during the quarter, compared to analysts’ expectations of $0.09 million. OvaScience had a negative return on equity of 69.13% and a negative net margin of 16,132.47%. The business’s revenue for the quarter was down 55.6% on a year-over-year basis. During the same quarter last year, the firm earned ($0.62) earnings per share. On average, analysts expect OvaScience to post $-1.71 EPS for the current fiscal year and $-1.28 EPS for the next fiscal year.
Shares of OvaScience Inc. (OVAS) opened at 1.43 on Wednesday. OvaScience Inc. has a 52-week low of $1.25 and a 52-week high of $5.89. The firm’s market cap is $51.03 million. The company’s 50-day moving average price is $1.40 and its 200-day moving average price is $1.45.
A number of research firms have issued reports on OVAS. Oppenheimer Holdings, Inc. reiterated a “hold” rating on shares of OvaScience in a report on Thursday, August 3rd. Zacks Investment Research upgraded shares of OvaScience from a “hold” rating to a “buy” rating and set a $1.50 price objective for the company in a research note on Wednesday, October 4th.
COPYRIGHT VIOLATION NOTICE: This news story was originally reported by American Banking News and is the sole property of of American Banking News. If you are accessing this news story on another domain, it was stolen and republished in violation of US and international trademark & copyright law. The original version of this news story can be accessed at https://www.americanbankingnews.com/2017/10/25/ovascience-inc-ovas-to-release-earnings-on-wednesday.html.
OvaScience, Inc is a global fertility company. The Company is focused on the discovery, development and commercialization of fertility treatment options for women. The Company’s portfolio of fertility treatment options uses its technology, including methods to identify and isolate Egg precursor (EggPC) cells from a patient’s own ovarian tissue.
Receive News & Ratings for OvaScience Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for OvaScience Inc. and related companies with MarketBeat.com's FREE daily email newsletter.